Guardant Net Income From Continuing Ops from 2010 to 2024

GH Stock  USD 17.96  0.27  1.53%   
Guardant Health's Net Loss is decreasing with slightly volatile movements from year to year. Net Loss is estimated to finish at about -455.5 M this year. For the period between 2010 and 2024, Guardant Health, Net Loss quarterly trend regression had median of (67,851,000) and r-value of (0.82). View All Fundamentals
 
Net Loss  
First Reported
2016-12-31
Previous Quarter
-86.1 M
Current Value
-187 M
Quarterly Volatility
59.3 M
 
Covid
Check Guardant Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guardant main balance sheet or income statement drivers, such as Tax Provision of 719.2 K, Net Interest Income of 34.4 M or Interest Income of 37.1 M, as well as many exotic indicators such as Price To Sales Ratio of 5.1, Dividend Yield of 0.0019 or Operating Cycle of 136. Guardant financial statements analysis is a perfect complement when working with Guardant Health Valuation or Volatility modules.
  
This module can also supplement Guardant Health's financial leverage analysis and stock options assessment as well as various Guardant Health Technical models . Check out the analysis of Guardant Health Correlation against competitors.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

Latest Guardant Health's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Guardant Health over the last few years. It is Guardant Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Guardant Health's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Guardant Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(185,258,303)
Coefficient Of Variation(111.12)
Mean Deviation172,570,004
Median(67,851,000)
Standard Deviation205,850,286
Sample Variance42374.3T
Range608.4M
R-Value(0.82)
Mean Square Error15091.2T
R-Squared0.67
Significance0.0002
Slope(37,657,042)
Total Sum of Squares593240.8T

Guardant Net Income From Continuing Ops History

2024-455.5 M
2023-479.4 M
2022-654.6 M
2021-384.8 M
2020-246.3 M
2019-67.9 M
2018-84.3 M

About Guardant Health Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Guardant Health income statement, its balance sheet, and the statement of cash flows. Guardant Health investors use historical funamental indicators, such as Guardant Health's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Guardant Health investors may use each financial statement separately, they are all related. The changes in Guardant Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Guardant Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Guardant Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Guardant Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Net Loss-479.4 M-455.5 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Guardant Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardant Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardant Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardant Health Stock:
Check out the analysis of Guardant Health Correlation against competitors.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.28)
Revenue Per Share
5.036
Quarterly Revenue Growth
0.222
Return On Assets
(0.18)
Return On Equity
(4.38)
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.